First melanoma test to offer reassurance of low risk of cancer spread

A new test reliably predicting the spread or return of the most deadly form of skin cancer has been developed by a team of scientists and clinicians from Newcastle University. The test, known as AMBLor®, is applied to a standard biopsy of the primary melanoma when it is removed.

The technological advance came as the Newcastle team made a scientific breakthrough in understanding the mechanism of skin cancer growth. Professor Penny Lovat, who led the work, has shared that the test will provide reassurance to patients who are diagnosed with an early stage melanoma.

read more